Ireland Cancer Center at Firelands Regional Medical Center — Sandusky, Ohio

Ireland Cancer Center at Firelands Regional Medical Center is a clinical research site located in Sandusky, Ohio, United States 44870.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Ireland Cancer Center at Firelands Regional Medical Center has participated in 16 clinical trials with 2 currently active.

Therapeutic areas: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, Radiation Therapy Oncology Group, ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ireland Cancer Center at Firelands Regional Medical Center?

Ireland Cancer Center at Firelands Regional Medical Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ireland Cancer Center at Firelands Regional Medical Center conducted?

Ireland Cancer Center at Firelands Regional Medical Center has 16 clinical trials on record, with 2 currently active. Their work covers Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Is Ireland Cancer Center at Firelands Regional Medical Center accredited by Crixeo Health?

Yes — Ireland Cancer Center at Firelands Regional Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Ireland Cancer Center at Firelands Regional Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.